Sana Biotechnology
Kyle Trudeau has a strong background in gene therapy research, starting in 2019 as a Senior Scientist at Sana Biotechnology, Inc. They progressed to roles such as Associate Director and Director before becoming the Senior Director of Gene Therapy Research. Prior to this, Kyle worked as a Contract Science Writer at JetPub Scientific Communications from 2017 to 2023. They also served as a Senior Scientist at Cobalt Biomedicine, Inc. from 2016 to 2019. In addition, Kyle had experience as a Postdoctoral Research Fellow at Boston Medical Center (BMC) and as a Consultant at Flagship VentureLabs, where they were involved in various in vitro and in vivo research projects. They began their career at Boston University School of Medicine, where they completed their Ph.D. and worked as a Graduate Student and Undergraduate Researcher.
Kyle Trudeau earned a Bachelor's degree in Biochemistry and Molecular Biology from Boston University from 2006 to 2010. Kyle then went on to complete their Doctor of Philosophy (Ph.D.) in Molecular and Translational Medicine at Boston University School of Medicine from 2010 to 2016.
This person is not in the org chart
This person is not in any offices
Sana Biotechnology
2 followers
Sana Biotechnology is focused on utilizing engineered cells as medicines for patients. The ability to modify genes and use cells as medicines will be one of the most important advances in healthcare over the next several decades. Sana is building differentiated capabilities across the spectrum of cell and gene therapy.